LINDA RYZNAR: Open Payments
NPI 1073632964 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,632 in 144 payments from 21 companies in 2025. Trend: 2023 $3,451 · 2024 $4,306 · 2025 $2,632
Food & beverage: $2,542Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $375 |
| GENZYME CORPORATION | 11 | $271 |
| Galderma Laboratories, L.P. | 24 | $263 |
| Regeneron Healthcare Solutions, Inc. | 10 | $238 |
| Organon LLC | 14 | $230 |
| Janssen Biotech, Inc. | 6 | $185 |
| E.R. Squibb & Sons, L.L.C. | 13 | $168 |
| Novartis Pharmaceuticals Corporation | 3 | $159 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $139 |
| Lilly USA, LLC | 8 | $118 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, VTAMA, Sotyktu, NEMLUVIO, ILUMYA, TALTZ.
Industry payments across MI — which companies pay providers there.
